Ph.D. Daniel Billen - Director at Aurinia Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AUPH on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ph.D. Daniel Billen since 30 Jan 2025

Holdings reported by Ph.D. Daniel Billen for Aurinia Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 28,141 $161,529 $5.74 21 May 2024 Direct
Stock Option (right to buy) 15,234 19 May 2023 Direct Common Stock
Restricted Stock Units 0 18 May 2023 Direct Common Stock

Transactions reported by Ph.D. Daniel Billen for Aurinia Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.